Cardio Diagnostics Holdings Collaborates on Cardiovascular Health Initiative...
Cardio Diagnostics Holdings, a developer of AI-driven precision cardiovascular medicine tests, announced a strategic collaboration with Truckers Health Network, an organization providing health and...
View ArticleAmerican College of Cardiology to Increase Cholesterol Screenings Through New...
The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is launching a new quality improvement campaign, “Driving Urgency in LDL Screening,” to increase the rate...
View ArticleNew Blood Test Measures Levels of Critical Omega-3 Fatty Acids
Researchers at McMaster and the University of Guelph discovered a convenient new way to track levels of omega-3 fatty acids in the bloodstream, making it much easier to access information that is...
View ArticleMindray Expands Cardiac Biomarker Portfolio with New Assays
Mindray, a global provider of medical devices and solutions, introduced high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers, which are aimed at diversifying its portfolio of cardiac...
View ArticleEarlier Detection of Pediatric Cardiometabolic Risk Factors through Next-Gen...
The next generation of cardiometabolic biomarkers should pave the way for earlier detection of risk factors for conditions such as obesity, diabetes, and heart disease in children, according to a new...
View ArticleBio-Rad Expands Instrument Compatibility for Cardiac Advance Control
Bio-Rad Laboratories, a global provider of life science research and clinical diagnostic products, expanded the compatibility of its newest cardiac control, Cardiac Advance, to now include...
View ArticleNew Test Aids Emergency Diagnosis of Heart Conditions
A trial in accident and emergency departments (A&E) found that a new way of measuring troponin—a protein released into the blood after a heart injury—could reduce future heart attacks in at-risk...
View ArticleTwo-Step Screening Strategy Could Reduce Diabetic Heart Failure
A two-step screening protocol that combines clinical risk assessment with biomarker testing can more effectively identify which patients with Type 2 diabetes need medication to prevent heart failure,...
View ArticleTwo Common Biomarkers Predict Heart Risk in Asymptomatic Childhood Cancer...
Data from the St. Jude lifetime cohort study revealed that two common biomarkers of cardiac function and damage could better predict cardiomyopathy within five years than routine clinical evaluations...
View ArticleBiomarkers to Predict Cardiovascular Risks in Type 2 Diabetes Patients...
An international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes. The analysis,...
View ArticleHow a Standard Blood Test Helps Predict Heart Attacks
Researchers have found that combining the results of a standard blood test and an online tool can help identify those who are at an increased risk of having a heart attack within six months. The tool...
View ArticleBlood Biomarkers Help Predict Cardiovascular Disease Risk in Rheumatoid...
A research team led by physicians at Mass General Brigham with expertise in rheumatology and cardiovascular disease identified six blood biomarkers that are associated with cardiovascular risk in...
View ArticleHeart Failure Monitoring Tech Doubles Sensitivity for Predicting Events...
Bodyport, a virtual care company focused on heart failure, announced data from a presentation that showed its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring...
View ArticleFDA Clears Cardiac Troponin I Test for Myocardial Infarction Diagnosis
A new high-sensitivity troponin assay developed for the PATHFAST Biomarker Analyzer from Polymedco received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Rapid Myocardial...
View ArticleAdvanced Cardiovascular POC Testing System Gets FDA Clearance
Analytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module. The CorVista System is an FDA-cleared, machine learned...
View Article
